{"id":"https://openalex.org/W4380148839","doi":"https://doi.org/10.1016/j.jval.2023.03.2740","title":"SA70 Patient-Reported Outcomes and Daily Activity Assessed with a Digital Wearable Device (FITBIT\u2122) in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: The Reveal Study","display_name":"SA70 Patient-Reported Outcomes and Daily Activity Assessed with a Digital Wearable Device (FITBIT\u2122) in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: The Reveal Study","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4380148839","doi":"https://doi.org/10.1016/j.jval.2023.03.2740"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2023.03.2740","doi":"https://doi.org/10.1016/j.jval.2023.03.2740","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.03.2740","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301523029303/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.valueinhealthjournal.com/article/S1098301523029303/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060452476","display_name":"Elizabeth A. Griffiths","orcid":"https://orcid.org/0000-0002-0288-8248","observed_orcids":["https://orcid.org/0000-0002-0288-8248"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E.A Griffiths","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029813144","display_name":"Anlin Wang","orcid":"https://orcid.org/0009-0000-9456-4365","observed_orcids":["https://orcid.org/0009-0000-9456-4365"]},"institutions":[{"id":"https://openalex.org/I4210125492","display_name":"Alexion Pharmaceuticals (United States)","ror":"https://ror.org/031ywxc85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125492"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Wang","raw_affiliation_strings":["Alexion, AstraZeneca Rare Disease, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion, AstraZeneca Rare Disease, Boston, MA, USA","institution_ids":["https://openalex.org/I4210125492"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038346531","display_name":"Ioannis Tomazos","orcid":"https://orcid.org/0000-0003-0290-4583","observed_orcids":["https://orcid.org/0000-0003-0290-4583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Tomazos","raw_affiliation_strings":["Alexion, AstraZeneca Rare Disease*, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion, AstraZeneca Rare Disease*, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015434169","display_name":"J.S Min","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099074","display_name":"Evidation Health (United States)","ror":"https://ror.org/00vhpak23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.S Min","raw_affiliation_strings":["Evidation Health*, San Mateo, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidation Health*, San Mateo, CA, USA","institution_ids":["https://openalex.org/I4210099074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046193504","display_name":"Wei-Nchih Lee","orcid":"https://orcid.org/0000-0002-0252-628X","observed_orcids":["https://orcid.org/0000-0002-0252-628X"]},"institutions":[{"id":"https://openalex.org/I4210099074","display_name":"Evidation Health (United States)","ror":"https://ror.org/00vhpak23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210099074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W.N Lee","raw_affiliation_strings":["Evidation Health, San Mateo, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidation Health, San Mateo, CA, USA","institution_ids":["https://openalex.org/I4210099074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102948832","display_name":"Yogesh Patel","orcid":"https://orcid.org/0000-0001-8948-4432","observed_orcids":["https://orcid.org/0000-0001-8948-4432"]},"institutions":[{"id":"https://openalex.org/I4210125492","display_name":"Alexion Pharmaceuticals (United States)","ror":"https://ror.org/031ywxc85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125492"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Patel","raw_affiliation_strings":["Alexion, AstraZeneca Rare Disease, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion, AstraZeneca Rare Disease, Boston, MA, USA","institution_ids":["https://openalex.org/I4210125492"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101792543","display_name":"Jing Hong Yu","orcid":"https://orcid.org/0000-0003-3815-8391","observed_orcids":["https://orcid.org/0000-0003-3815-8391"]},"institutions":[{"id":"https://openalex.org/I4210125492","display_name":"Alexion Pharmaceuticals (United States)","ror":"https://ror.org/031ywxc85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125492"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Yu","raw_affiliation_strings":["Alexion, AstraZeneca Rare Disease, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexion, AstraZeneca Rare Disease, Boston, MA, USA","institution_ids":["https://openalex.org/I4210125492"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007747233","display_name":"David Dingli","orcid":"https://orcid.org/0000-0001-7477-3004","observed_orcids":["https://orcid.org/0000-0001-7477-3004"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Dingli","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"6","first_page":"S409","last_page":"S409"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9380000233650208,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9380000233650208,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.017899999395012856,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paroxysmal-nocturnal-hemoglobinuria","display_name":"paroxysmal nocturnal hemoglobinuria","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ravulizumab","display_name":"ravulizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.9240000247955322},{"id":"https://openalex.org/keywords/wearable-devices","display_name":"wearable devices","score":0.5630000233650208},{"id":"https://openalex.org/keywords/fitbit","display_name":"Fitbit","score":0.8799999952316284},{"id":"https://openalex.org/keywords/daily-physical-activity","display_name":"daily physical activity","score":0.6899999976158142},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.7409999966621399},{"id":"https://openalex.org/keywords/complement-inhibition-therapy","display_name":"complement inhibition therapy","score":0.40400001406669617},{"id":"https://openalex.org/keywords/patient-experience","display_name":"patient experience","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C2777346216","wikidata":"https://www.wikidata.org/wiki/Q1479494","display_name":"Paroxysmal nocturnal hemoglobinuria","level":2,"score":0.9664641618728638},{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.7067455649375916},{"id":"https://openalex.org/C150594956","wikidata":"https://www.wikidata.org/wiki/Q1334829","display_name":"Wearable computer","level":2,"score":0.6518170833587646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5481536388397217},{"id":"https://openalex.org/C2777334680","wikidata":"https://www.wikidata.org/wiki/Q1607611","display_name":"Nocturnal","level":2,"score":0.5329918265342712},{"id":"https://openalex.org/C2778639011","wikidata":"https://www.wikidata.org/wiki/Q1553850","display_name":"Hemoglobinuria","level":3,"score":0.4259389042854309},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28488075733184814},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.22803613543510437},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.12809306383132935},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09891006350517273},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C149635348","wikidata":"https://www.wikidata.org/wiki/Q193040","display_name":"Embedded system","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2023.03.2740","doi":"https://doi.org/10.1016/j.jval.2023.03.2740","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.03.2740","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301523029303/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2023.03.2740","doi":"https://doi.org/10.1016/j.jval.2023.03.2740","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.03.2740","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301523029303/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4380148839.pdf","grobid_xml":"https://content.openalex.org/works/W4380148839.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4401456379","https://openalex.org/W4380150122","https://openalex.org/W7133579919","https://openalex.org/W4405041500","https://openalex.org/W4376115118","https://openalex.org/W7134195765","https://openalex.org/W4283370556","https://openalex.org/W2988309127","https://openalex.org/W3111386845","https://openalex.org/W4399699911"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-06-11T00:00:00"}